Paloma Partners’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-13,625
| Closed | -$346K | – | 2367 |
|
|
2020
Q2 | $346K | Buy |
+13,625
| New | +$346K | 0.01% | 1269 |
|
|
2017
Q3 | – | Sell |
-160,000
| Closed | -$507K | – | 1863 |
|
|
2017
Q2 | $507K | Hold |
160,000
| – | – | 0.01% | 1074 |
|
|
2017
Q1 | $544K | Buy |
160,000
+53,131
| +50% | +$181K | 0.01% | 1096 |
|
|
2016
Q4 | $308K | Buy |
+106,869
| New | +$308K | ﹤0.01% | 1245 |
|
|
2016
Q3 | – | Sell |
-60,979
| Closed | -$183K | – | 1719 |
|
|
2016
Q2 | $183K | Buy |
+60,979
| New | +$183K | ﹤0.01% | 1550 |
|